A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19
Stopped early · Phase 2/Phase 3 · Has a placebo group
Conditions studied: COVID-19
In brief
The purpose of this study is to establish the antiviral efficacy of ensovibep against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in humans, identify the optimal dose, and demonstrate its clinical value for treating COVID-19 in adult ambulatory patients.
Key facts
- Study ID
- NCT04828161
- Run by
- Novartis Pharmaceuticals
- People needed
- 407
- Starts
- 2021-05-10
- Expected to finish
- 2022-01-27
- Last updated by the study team
- 2026-01-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Jasper Summit Research, LLC — Jasper, Alabama, United States
- Benchmark Southern California — Colton, California, United States
- Ascada Research — Fullerton, California, United States
- Pacific Neuropsychiatric Specialists — Mission Viejo, California, United States
- Providence Family Medical Center — Redondo Beach, California, United States
- Future Innovative Treatments — Colorado Springs, Colorado, United States
- Boward Infectious Disease and Primary Care — Margate, Florida, United States
- Suncoast Research Group, LLC — Miami, Florida, United States
- Life Spring Research Foundation — Miami, Florida, United States
- Bio-Medical Research, LLC — Miami, Florida, United States
- Panax Clinical Research, LLC — Miami Lakes, Florida, United States
- AdventHealth Tampa — Tampa, Florida, United States
- Palm Beach Research Center — West Palm Beach, Florida, United States
- Gwinnett Research Institute — Buford, Georgia, United States
- IACT Health — Columbus, Georgia, United States
- Great Lakes Clinical Trials — Chicago, Illinois, United States
- Centennial Medical Group - Research Department — Elkridge, Maryland, United States
- Jefferson City Medical Group — Jefferson City, Missouri, United States
- Monroe Biomedical Research — Monroe, North Carolina, United States
- Wilmington Health — Wilmington, North Carolina, United States
- VitaLink Research — Greenville, South Carolina, United States
- Clinical Research of Rock Hill — Rock Hill, South Carolina, United States
- Fairway Medical Clinic — Houston, Texas, United States
- 1960 Family Practice, PA — Houston, Texas, United States
- Zion Urgent Care Clinic — Katy, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.